What is the recommended dose of indomethacin (Non-Steroidal Anti-Inflammatory Drug (NSAID)) for treating pericarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Indomethacin Dosing for Pericarditis

For pericarditis, start indomethacin at 25 mg every 8 hours (75 mg/day total) and titrate upward to a maximum of 50 mg every 8 hours (150 mg/day total) as needed for symptom control, but recognize that ibuprofen is the preferred NSAID due to indomethacin's adverse effect on coronary blood flow. 1, 2

Initial Dosing Strategy

  • Start at the lower end of the dosing range (25 mg every 8 hours) to minimize side effects, particularly headache and dizziness which are common with indomethacin 1, 2
  • Titrate upward toward 50 mg every 8 hours only if symptoms are not adequately controlled at the lower dose 1, 2
  • The total daily dose range is 75-150 mg/day divided into three doses 2

Treatment Duration and Tapering

  • Continue treatment for weeks to months until symptoms resolve and C-reactive protein (CRP) normalizes 1
  • Taper by decreasing the dose by 25 mg every 1-2 weeks once symptoms are absent and CRP is normal 1, 2
  • Longer tapering periods may be necessary for difficult or resistant cases 1
  • Never attempt tapering while symptoms persist or CRP remains elevated, as premature discontinuation is a major cause of recurrence 1, 2, 3

Critical Considerations: Why Indomethacin Is NOT First-Line

  • Indomethacin reduces coronary blood flow and should be avoided in elderly patients and those with coronary artery disease 2
  • The European Society of Cardiology explicitly recommends ibuprofen (600 mg every 8 hours) as the preferred NSAID due to its superior safety profile and favorable impact on coronary flow 2, 3
  • Indomethacin may only be considered in younger patients without coronary disease when ibuprofen or aspirin are contraindicated or not tolerated 2

Mandatory Adjunctive Therapy

  • Always add colchicine to any NSAID regimen at weight-adjusted doses: 0.5 mg once daily if <70 kg or 0.5 mg twice daily if ≥70 kg for at least 3 months 1, 2, 3
  • Colchicine reduces recurrence risk from 37.5% to 16.7% (absolute risk reduction 20.8%) when added to NSAIDs 4, 5
  • Use gastroprotection with all NSAID therapy 3

Common Pitfalls to Avoid

  • Do not use indomethacin as first-line therapy—ibuprofen is safer and equally effective 2
  • Do not use NSAIDs as monotherapy without colchicine, as this dramatically increases recurrence rates 2, 3
  • Do not stop treatment before CRP normalization, even if symptoms improve, as inadequate treatment duration is the most common cause of recurrence 2, 3
  • Do not use indomethacin in elderly patients or those with known coronary disease due to coronary flow reduction 2

When to Escalate Therapy

  • If symptoms persist despite appropriate NSAID doses and colchicine, consider adding low-dose corticosteroids (prednisone 0.2-0.5 mg/kg/day) as triple therapy rather than replacing NSAIDs 1
  • Corticosteroids should not be first-line as they promote chronicity and increase recurrence rates 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pericarditis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Treatment for Pericarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A randomized trial of colchicine for acute pericarditis.

The New England journal of medicine, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.